Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Monte Rosa Therapeutics IncCommon Stock stock

Learn how to easily invest in Monte Rosa Therapeutics IncCommon Stock stock.

Monte Rosa Therapeutics, Inc. Common Stock is a biotechnology business based in the US. Monte Rosa Therapeutics IncCommon Stock shares (GLUE) are listed on the NASDAQ and all prices are listed in US Dollars. Monte Rosa Therapeutics IncCommon Stock employs 60 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Monte Rosa Therapeutics IncCommon Stock

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – GLUE – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Monte Rosa Therapeutics IncCommon Stock stock price (NASDAQ: GLUE)

Use our graph to track the performance of GLUE stocks over time.

Monte Rosa Therapeutics IncCommon Stock shares at a glance

Information last updated 2021-07-28.
52-week range$18.01 - $24.86
50-day moving average $20.66
200-day moving average $20.66
Wall St. target priceN/A
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) N/A

Buy Monte Rosa Therapeutics IncCommon Stock shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Robinhood
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Public
Stocks, ETFs
N/A
$0 per month
Download and sign up with Public.com; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
Webull
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
0%
N/A
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Moomoo
Stocks, Options, ETFs
$0
$0 per year
N/A
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Monte Rosa Therapeutics IncCommon Stock stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Monte Rosa Therapeutics IncCommon Stock financials

Gross profit TTM $0
Return on assets TTM 0%
Return on equity TTM 0%
Profit margin 0%
Book value N/A
Market capitalisation $1 billion

TTM: trailing 12 months

Shorting Monte Rosa Therapeutics IncCommon Stock shares

There are currently 659,973 Monte Rosa Therapeutics IncCommon Stock shares held short by investors – that's known as Monte Rosa Therapeutics IncCommon Stock's "short interest". This figure is 10.5% down from 737,322 last month.

There are a few different ways that this level of interest in shorting Monte Rosa Therapeutics IncCommon Stock shares can be evaluated.

Monte Rosa Therapeutics IncCommon Stock's "short interest ratio" (SIR)

Monte Rosa Therapeutics IncCommon Stock's "short interest ratio" (SIR) is the quantity of Monte Rosa Therapeutics IncCommon Stock shares currently shorted divided by the average quantity of Monte Rosa Therapeutics IncCommon Stock shares traded daily (recently around 549977.5). Monte Rosa Therapeutics IncCommon Stock's SIR currently stands at 1.2. In other words for every 100,000 Monte Rosa Therapeutics IncCommon Stock shares traded daily on the market, roughly 1200 shares are currently held short.

To gain some more context, you can compare Monte Rosa Therapeutics IncCommon Stock's short interest ratio against those of similar companies.

However Monte Rosa Therapeutics IncCommon Stock's short interest can also be evaluated against the total number of Monte Rosa Therapeutics IncCommon Stock shares, or, against the total number of tradable Monte Rosa Therapeutics IncCommon Stock shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Monte Rosa Therapeutics IncCommon Stock's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Monte Rosa Therapeutics IncCommon Stock shares in existence, roughly 10 shares are currently held short) or 0.7023% of the tradable shares (for every 100,000 tradable Monte Rosa Therapeutics IncCommon Stock shares, roughly 702 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Monte Rosa Therapeutics IncCommon Stock.

Find out more about how you can short Monte Rosa Therapeutics IncCommon Stock stock.

Monte Rosa Therapeutics IncCommon Stock share dividends

We're not expecting Monte Rosa Therapeutics IncCommon Stock to pay a dividend over the next 12 months.

Monte Rosa Therapeutics IncCommon Stock overview

Monte Rosa Therapeutics, Inc. , a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing protein for the treatment of Myc-driven cancers. The company also develops CDK2 to treat ovarian, uterine, and breast cancers; NEK7 for the treatment of inflammatory diseases, such as Crohn's disease, neurodegenerative disease, diabetes, and liver disease; VAV1, a target protein for autoimmune diseases; and BCL11A, a therapeutically-relevant protein in hemoglobinopathies. Monte Rosa Therapeutics, Inc. was incorporated in 2019 and is based in Boston, Massachusetts. .

Frequently asked questions

What percentage of Monte Rosa Therapeutics IncCommon Stock is owned by insiders or institutions?
Currently 0.979% of Monte Rosa Therapeutics IncCommon Stock shares are held by insiders and 50.12% by institutions.
How many people work for Monte Rosa Therapeutics IncCommon Stock?
Latest data suggests 60 work at Monte Rosa Therapeutics IncCommon Stock.
When does the fiscal year end for Monte Rosa Therapeutics IncCommon Stock?
Monte Rosa Therapeutics IncCommon Stock's fiscal year ends in December.
Where is Monte Rosa Therapeutics IncCommon Stock based?
Monte Rosa Therapeutics IncCommon Stock's address is: 645 Summer Street, Boston, MA, United States, 02210

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site